Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sandford D. Smith currently holds 18,801 shares of NOVELION THERAPEUTICS INC. (NVLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sandford D. Smith has been a net seller of NVLN stock. They have purchased $41.6K and sold $17.9M worth of shares.
Sandford D. Smith's most recent insider trade was on Jan 2, 2024, when they sold 148 shares at $84.12 per share.
Sandford D. Smith serves as Executive at NOVELION THERAPEUTICS INC. (NVLN). They have executed 152 insider transactions totaling $17.9M over their tenure at the company.
Sandford D. Smith holds the position of Executive at NOVELION THERAPEUTICS INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Sandford D. Smith has shown a selling trading pattern, with $41.6K in total purchases and $17.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sandford D. Smith was on Dec 27, 2021, when they sold $915.8K worth of CYTK shares. This transaction involved 20,000 shares at $45.79 per share.
Sandford D. Smith currently owns 18,801 shares of NOVELION THERAPEUTICS INC. (NVLN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sandford D. Smith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sandford D. Smith has 152 Form 4 filings on record as an insider at NOVELION THERAPEUTICS INC..
Set alerts for Sandford D. Smith and 40,000+ other insiders.